- Crohn's disease Induction of remission in patients with mild to moderate active Crohn's disease affecting the ileum and/or the ascending colon - Microscopic colitis - Autoimmune hepatitis
Induction of remission in patients with mild to moderate active Crohn's disease affecting the ileum and/or the ascending colon Induction of remission in patients with active microscopic colitis in adults aged ≥ 18 years.
Crohn's disease - Induction of remission in patients with mild to moderate active Crohn's disease affecting the ileum and/or the ascending colon. Microscopic colitis - Induction of remission in patients with active microscopic colitis Maintenance of remission in patients with microscopic colitis.
For the treatment of metabolic acidosis and for maintenance treatment against recurrence of metabolic acidosis in adults with chronic renal impairment.
Esomeprazole capsules are indicated in adults and adolescents from the age of 12 years. Adults Gastro-Esophageal Reflux Disease (GERD) - treatment of erosive reflux esophagitis - long-term management of patients with healed esophagitis to prevent relapse - symptomatic treatment of gastro-esophageal reflux disease (GERD) In combination with appropriate antibacterial therapeutic regimens for the eradication of Helicobacter pylori and - healing of Helicobacter pylori associated duodenal ulcer and - prevention of relapse of peptic ulcers in patients with Helicobacter pylori associated ulcers. Patients requiring continued NSAID therapy - healing of gastric ulcers associated with NSAID therapy - prevention of gastric and duodenal ulcers associated with NSAID therapy, in patients at risk Prolonged treatment after i.v. induced prevention of rebleeding of peptic ulcers Treatment of Zollinger Ellison Syndrome Adolescents from the age of 12 years Gastro-Esophageal Reflux Disease (GERD) - treatment of erosive reflux esophagitis - long-term management of patients with healed esophagitis to prevent relapse - symptomatic treatment of gastro-esophageal reflux disease (GERD) In combination with antibiotics in treatment of duodenal ulcer caused by Helicobacter pylori
Tecfidera is indicated for the treatment of adult and paediatric patients. aged 13 years and older with relapsing remitting multiple sclerosis (RRMS).
Herbal medicinal product for the symptomatic relief of abdominal pain, minor spasms of the gastrointestinal tract, and flatulence, especially in patients with irritable bowel syndrome. Buscomint Peppermint oil 0.2ml gastro-resistant capsule, soft is indicated for use in adults and adolescents 12 years of age and above (who weigh at least 40 kg).
Prophylaxis of transplant rejection in adult kidney or liver allograft recipients. Treatment of allograft rejection resistant to treatment with other immunosuppressive medicinal products in adult patients.
Raptor Pharmaceutical Corp. announced that the European Commission has approved Procysbi, gastro-resistant hard capsules of cysteamine (as mercaptamine bitartrate) as...